Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The hypothesis of this study is that injection of botulinum toxin A into the muscles around
the head (frontal, temporal, posterior neck, occipital) can reduce the intensity and
frequency of migraine headaches by 50%.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Yale University
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA